Coveris’ security labels also work seamlessly with self-checkouts where around 80% of retail sales now typically occur
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
PREVENAR offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of currently circulating pneumococcal disease in the EU and globally
Two main objectives are: Accelerate novel technologies and products for global markets; and Connect academia and industry, creating synergy for faster advancement of the Bioprotection sector
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
Pharmaceutical manufacturer uses Veeam solutions to accelerate mission-critical backups by 95% and restore data in minutes, not hours
The study was conducted in equal laboratory conditions in the Spallanzani Institute in Italy on comparable sera samples from individuals vaccinated with Sputnik V and Pfizer with a similar level of IgG antibodies and virus-neutralizing activity (VNA) against Wuhan variant.
Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap
Subscribe To Our Newsletter & Stay Updated
